首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Post-operative albumin-bilirubin grade predicts long-term outcomes among Child–Pugh grade A patients with hepatocellular carcinoma after curative resection
【24h】

Post-operative albumin-bilirubin grade predicts long-term outcomes among Child–Pugh grade A patients with hepatocellular carcinoma after curative resection

机译:术后白蛋白-胆红素等级可预测Child–Pugh A级肝细胞癌根治性切除术后的长期预后

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Although Child–Pugh grade A patients with hepatocellular carcinoma (HCC) are candidates for curative resection, some may have a poor prognosis. The albumin-bilirubin (ALBI) grade, a measure of liver function based on albumin and bilirubin, has the potential to detect Child–Pugh grade A HCC patients with poor prognosis. Because components of the ALBI grade can be measured easily even after surgery, we explored the predictive values of ALBI in patient prognosis after HCC resection. Methods: In this retrospective case-control study, we included 136 HCC patients who underwent curative resection between January 2004 and December 2013 at our hospital. ALBI grade was calculated from laboratory data recorded the day before surgery and at post-operative day 5. Results: Pre- and post-operative ALBI grade predicted patients' long-term outcomes (P = 0.020 and P < 0.001, respectively, for overall survival, and P = 0.012 and P = 0.015, respectively, for recurrence-free survival). Post-operative ALBI grade was associated with patients' surgical factors of repeated hepatic re-section (P = 0.012), intra-operative bleeding (P = 0.006), and surgery duration (P = 0.033). Furthermore, post-operative ALBI grade, rather than pre-operative ALBI grade, was an independent predictive factor of long-term outcome of Child–Pugh grade A patients with HCC. Conclusions: Post-operative ALBI grade is useful to predict the prognosis in patients after HCC resection.
机译:背景:尽管Child–Pugh A级肝细胞癌(HCC)患者可以进行根治性切除,但有些患者预后较差。白蛋白-胆红素(ALBI)等级是一种基于白蛋白和胆红素的肝功能测量指标,具有检测预后不良的Child-Pugh A级肝癌患者的潜力。因为即使在手术后也可以轻松测量ALBI等级的成分,所以我们探讨了ALBI在HCC切除后对患者预后的预测价值。方法:在这项回顾性病例对照研究中,我们纳入了2004年1月至2013年12月间在我院进行根治性切除的136例HCC患者。 ALBI等级是根据手术前一天和术后第5天记录的实验室数据计算得出的。结果:术前和术后ALBI等级预测了患者的长期结局(分别为P = 0.020和P <0.001,无复发生存率分别为P = 0.012和P = 0.015)。术后ALBI等级与患者手术重复肝切除的手术因素(P = 0.012),术中出血(P = 0.006)和手术时间(P = 0.033)相关。此外,术后ALBI等级而非术前ALBI等级是Child–Pugh A级肝癌患者长期预后的独立预测因素。结论:术后ALBI分级有助于预测肝癌切除术后的预后。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2018年第006期|502-509|共8页
  • 作者单位

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

    Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8503, Japan;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:27:21
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号